Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.
To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html
The financial opportunity within the liquid biopsy and other non-invasive cancer diagnostics market has been analyzed across the following segments:
Type of Tumor Marker
ctDNAcfDNACTCsExosomesOthersApplication
Diagnosis / Early DiagnosisPatient MonitoringRecurrence MonitoringTarget Cancer Indication
Breast CancerLung CancerColorectal CancerProstate CancerBladder CancerMelanomaGastric CancerPancreatic CancerOvarian CancerOthersEnd Users
HospitalsResearch InstitutesOthersKey Geographical Regions
North AmericaEuropeAsia-PacificRest of the WorldThe “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers.”report features the following companies, which we identified to be key players in this domain:
Amoy Diagnostics
DiaCarta
HaploX Biotechnology
NeoGenomics
QIAGEN
Swift Biosciences
Sysmex Inostics
Thermo Fisher Scientific
To request for sample report - https://www.rootsanalysis.com/reports/279/request-sample.html
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Non-Invasive Cancer Screening and Diagnosis
5. Market Landscape
6. Company Profiles
7. Partnerships and Collaborations
8. Funding and Investment Analysis
9. Liquid Biopsy: Initiatives of Big Pharma Players
10. Key Acquisition Targets
11. Other Non-Invasive Cancer Diagnostics
12. Market Sizing and Opportunity Analysis
13. Survey Insights
14. Conclusion
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Other Recent Offerings:
Antibody Drug Conjugates Market (5th Edition), 2019-2030Gene Therapy Market (3rd Edition), 2019 - 2030Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis